Skip to main content

Lion Point Capital, LP

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 1643354 NEW YORK, NY

Position in SNDX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$840,960
+$84,600 QoQ
Shares Held
36,000
0.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
5.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Lion Point Capital, LP holds $14,988,225 across 30 Biotechnology names. SNDX ranks #6 (5.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 SNDX
Syndax Pharmaceuticals Inc
This page
36,000 $840,960

All Filings in SNDX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $840,960 36,000
2025-12-31 $756,360 36,000
2025-09-30 $846,175 55,000
2025-06-30 $515,075 55,000
2025-03-31 $675,675 55,000
2024-12-31 $727,100 55,000
2024-09-30 $889,350 46,200
2024-06-30 $1,334,450 65,000
2024-03-31 $1,547,000 65,000
2023-12-31 $745,545 34,500
2023-09-30 $500,940 34,500
2023-06-30 $722,085 34,500